Clinical Trial Update: A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

View source ↗

Summary

This clinical trial update indicates that a study evaluating the safety of mavacamten in Korean patients with symptomatic obstructive hypertrophic cardiomyopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obstructive Hypertrophic Cardiomyopathy | Status: RECRUITING